2012

Profermin is efficacious in patients with active ulcerative colitis–a randomized controlled trial

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn’s Disease

Abatacept for Crohn’s Disease and Ulcerative Colitis

A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn’s disease

Adalimumab in patients with CD from Japan

Adalimumab, azathioprine or 5ASA in postoperative recurrence in CD

Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis

Ustekinumab in CD

Budesonide MMX in UC

Cyclosporin vs infliximab in ASUC